IFWM
SBIO icon

Institute for Wealth Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Institute for Wealth Management’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.27K Buy
+66
New +$3.62K ﹤0.01% 1474

Other funds holding SBIO

LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MWM
Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
FFASIA
FIG FINANCIAL ADVISORY SERVICES INC /ADV Oklahoma City, Oklahoma $171M AUM 27.06% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.65B AUM 29.37% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BFPW
BOK Financial Private Wealth Denver, Colorado $1.95B AUM 20.52% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Institute for Wealth Management's SBIO Position: Q2 2026 in Review

Institute for Wealth Management opened a new position in ALPS Medical Breakthroughs ETF (SBIO) in Q2 2026: 66 shares worth $4.27K. The stake represents ﹤0.01% of the portfolio and ranks #1474 among its holdings.

38 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • Institute for Wealth Management held 66 shares of ALPS Medical Breakthroughs ETF worth $4.27K as of Q2 2026.
  • ALPS Medical Breakthroughs ETF was a new Institute for Wealth Management position in Q2 2026.
  • ALPS Medical Breakthroughs ETF made up ﹤0.01% of Institute for Wealth Management's portfolio in Q2 2026, its #1474 holding.
  • 38 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Institute for Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.